PT1578325E - Composições estáveis para entrega tópica de fármacos - Google Patents
Composições estáveis para entrega tópica de fármacos Download PDFInfo
- Publication number
- PT1578325E PT1578325E PT03815011T PT03815011T PT1578325E PT 1578325 E PT1578325 E PT 1578325E PT 03815011 T PT03815011 T PT 03815011T PT 03815011 T PT03815011 T PT 03815011T PT 1578325 E PT1578325 E PT 1578325E
- Authority
- PT
- Portugal
- Prior art keywords
- drug delivery
- delivery compositions
- topical drug
- stable topical
- drug
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000012377 drug delivery Methods 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43727902P | 2002-12-31 | 2002-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1578325E true PT1578325E (pt) | 2011-07-08 |
Family
ID=32713159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT03815011T PT1578325E (pt) | 2002-12-31 | 2003-12-31 | Composições estáveis para entrega tópica de fármacos |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1578325B1 (pt) |
| JP (2) | JP5241995B2 (pt) |
| KR (1) | KR100767097B1 (pt) |
| CN (1) | CN100551345C (pt) |
| AT (1) | ATE506969T1 (pt) |
| AU (1) | AU2003303517C1 (pt) |
| BR (1) | BR0317876A (pt) |
| CA (1) | CA2511849C (pt) |
| DE (1) | DE60336925D1 (pt) |
| DK (1) | DK1578325T3 (pt) |
| ES (1) | ES2362412T3 (pt) |
| IL (1) | IL169169A (pt) |
| MX (1) | MXPA05007023A (pt) |
| PT (1) | PT1578325E (pt) |
| WO (1) | WO2004060315A2 (pt) |
| ZA (1) | ZA200505191B (pt) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040018237A1 (en) | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| MXPA05007023A (es) * | 2002-12-31 | 2005-09-12 | V Perricone Nicholas | Composiciones de suministro de farmaco topicas, estables. |
| EP2548581A3 (en) | 2005-06-17 | 2013-02-20 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| EP2076274A4 (en) * | 2006-09-11 | 2010-08-04 | Biomas Ltd | TOPICAL FORMULATIONS OF COMPOUNDS CONTAINING TELLURE |
| WO2009101412A1 (en) * | 2008-02-13 | 2009-08-20 | Cipla Limited | Topical pharmaceutical composition |
| AU2011213557B2 (en) | 2010-02-05 | 2015-05-07 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| US8652511B2 (en) | 2010-03-30 | 2014-02-18 | Phosphagenics Limited | Transdermal delivery patch |
| US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
| US8668937B2 (en) | 2011-03-17 | 2014-03-11 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems and methods of use thereof |
| CN105050549B (zh) | 2012-08-10 | 2017-07-21 | 阿尔图拉医疗公司 | 支架输送系统以及相关方法 |
| US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
| US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
| US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
| US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
| US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
| US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
| US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
| TW201440742A (zh) * | 2012-12-10 | 2014-11-01 | Uni Charm Corp | 吸收性物品及安裝構件 |
| US20140271742A1 (en) * | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Skin tanning using peptides and other compositions |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US20140271938A1 (en) * | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US20140271731A1 (en) * | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9849160B2 (en) * | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9393265B2 (en) * | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| CN104840422A (zh) * | 2014-02-18 | 2015-08-19 | 北京大学 | 一种长循环硅质体及其制备方法 |
| CN108601732A (zh) | 2015-12-09 | 2018-09-28 | 磷肌酸有限公司 | 药物制剂 |
| IL267006B2 (en) | 2016-12-21 | 2024-11-01 | Phosphagenics Ltd | Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof |
| US20240294603A1 (en) * | 2023-03-02 | 2024-09-05 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of spadin for treatment of depression or other indications |
| US11980651B1 (en) | 2023-06-21 | 2024-05-14 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of hearing using dihexa |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS607932A (ja) * | 1983-06-29 | 1985-01-16 | Dai Ichi Seiyaku Co Ltd | リポソーム懸濁液およびその製法 |
| US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
| DE4208552A1 (de) * | 1992-03-17 | 1993-09-23 | Liedtke Pharmed Gmbh | Topische arzneiformen mit insulin |
| DE59500419D1 (de) * | 1994-02-01 | 1997-08-28 | Theodor Dipl Ing Krall | Verfahren zur herstellung von bakteriziden/fungiziden kunststoffkörpern |
| US5858398A (en) * | 1994-11-03 | 1999-01-12 | Isomed Inc. | Microparticular pharmaceutical compositions |
| CA2181390C (en) * | 1995-07-18 | 2001-04-24 | Pankaj Modi | Phospholipid formulations |
| CN1151323A (zh) * | 1995-11-28 | 1997-06-11 | 华中理工大学 | 多肽类药物粘膜吸收剂型的促进剂 |
| CN1224360A (zh) * | 1996-07-02 | 1999-07-28 | 科特克斯(英国)有限公司 | 包含中链单酸甘油酯的疏水性制剂 |
| US6214375B1 (en) * | 1996-07-16 | 2001-04-10 | Generex Pharmaceuticals, Inc. | Phospholipid formulations |
| JPH10194994A (ja) * | 1997-01-16 | 1998-07-28 | Pola Chem Ind Inc | 吸収促進組成物 |
| JPH1179975A (ja) * | 1997-09-05 | 1999-03-23 | Mitsui Chem Inc | マイクロカプセルの調製法 |
| JP2000086501A (ja) * | 1998-09-11 | 2000-03-28 | Sankyo Co Ltd | ヒトカルシトニンのリポソーム製剤 |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| JP2003520210A (ja) * | 2000-01-05 | 2003-07-02 | イマレックス セラピューティクス， インコーポレイテッド | 低い水溶性を有する薬物の送達のための薬学的処方物 |
| US6191121B1 (en) * | 2000-04-06 | 2001-02-20 | Nicholas V. Perricone | Treatment of skin damage using polyenylphosphatidylcholine |
| KR20020066778A (ko) * | 2001-02-13 | 2002-08-21 | 한국과학기술연구원 | 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법 |
| KR100508695B1 (ko) * | 2001-02-13 | 2005-08-17 | 한국과학기술연구원 | 인슐린의 경구투여용 제형과 그의 제조방법 |
| MXPA05007023A (es) * | 2002-12-31 | 2005-09-12 | V Perricone Nicholas | Composiciones de suministro de farmaco topicas, estables. |
-
2003
- 2003-12-31 MX MXPA05007023A patent/MXPA05007023A/es active IP Right Grant
- 2003-12-31 CA CA2511849A patent/CA2511849C/en not_active Expired - Fee Related
- 2003-12-31 AU AU2003303517A patent/AU2003303517C1/en not_active Ceased
- 2003-12-31 CN CNB2003801080200A patent/CN100551345C/zh not_active Expired - Fee Related
- 2003-12-31 PT PT03815011T patent/PT1578325E/pt unknown
- 2003-12-31 JP JP2004565850A patent/JP5241995B2/ja not_active Expired - Fee Related
- 2003-12-31 ES ES03815011T patent/ES2362412T3/es not_active Expired - Lifetime
- 2003-12-31 DE DE60336925T patent/DE60336925D1/de not_active Expired - Lifetime
- 2003-12-31 DK DK03815011.6T patent/DK1578325T3/da active
- 2003-12-31 BR BR0317876-5A patent/BR0317876A/pt not_active Application Discontinuation
- 2003-12-31 KR KR1020057012203A patent/KR100767097B1/ko not_active Expired - Fee Related
- 2003-12-31 WO PCT/US2003/041671 patent/WO2004060315A2/en not_active Ceased
- 2003-12-31 AT AT03815011T patent/ATE506969T1/de active
- 2003-12-31 EP EP03815011A patent/EP1578325B1/en not_active Expired - Lifetime
-
2005
- 2005-06-15 IL IL169169A patent/IL169169A/en active IP Right Grant
- 2005-06-27 ZA ZA200505191A patent/ZA200505191B/en unknown
-
2010
- 2010-03-04 JP JP2010047781A patent/JP2010159278A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1578325A2 (en) | 2005-09-28 |
| MXPA05007023A (es) | 2005-09-12 |
| ZA200505191B (en) | 2006-04-26 |
| IL169169A (en) | 2010-12-30 |
| ATE506969T1 (de) | 2011-05-15 |
| BR0317876A (pt) | 2005-12-06 |
| CN1731963A (zh) | 2006-02-08 |
| CN100551345C (zh) | 2009-10-21 |
| EP1578325A4 (en) | 2006-09-13 |
| CA2511849C (en) | 2012-05-15 |
| WO2004060315A2 (en) | 2004-07-22 |
| DE60336925D1 (de) | 2011-06-09 |
| KR20050094829A (ko) | 2005-09-28 |
| WO2004060315A3 (en) | 2004-09-30 |
| DK1578325T3 (da) | 2011-08-08 |
| AU2003303517C1 (en) | 2008-04-24 |
| AU2003303517B2 (en) | 2007-10-25 |
| JP2006518710A (ja) | 2006-08-17 |
| KR100767097B1 (ko) | 2007-10-15 |
| IL169169A0 (en) | 2007-07-04 |
| AU2003303517A1 (en) | 2004-07-29 |
| ES2362412T3 (es) | 2011-07-05 |
| HK1081878A1 (zh) | 2006-05-26 |
| JP5241995B2 (ja) | 2013-07-17 |
| EP1578325B1 (en) | 2011-04-27 |
| CA2511849A1 (en) | 2004-07-22 |
| JP2010159278A (ja) | 2010-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL169169A0 (en) | Stable topical drug delivery compositions | |
| MY141521A (en) | 5-substituted-six-membered heteroaromatic glucokinase activators | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| YU75701A (sh) | Farmaceutski preparat | |
| TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| GB0215844D0 (en) | Organic compounds | |
| CY1113003T1 (el) | Ευσταθη παρασκευασματα laquinimod | |
| WO2008108286A1 (ja) | 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤 | |
| HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
| GB9800526D0 (en) | Organic compounds | |
| BR0315927A (pt) | Unidades para doses únicas diárias de melatonina | |
| AU2002214389A1 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
| MXPA05010020A (es) | Derivados de oxamida. | |
| WO2009019708A3 (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
| PT1638582E (pt) | Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal | |
| TNSN07203A1 (en) | Pharmaceutical compositions for the treatment of cellulite | |
| ATE393624T1 (de) | Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs | |
| UA89795C2 (ru) | Фармацевтическая композиция, которая содержит эстер темозоломида | |
| ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
| TNSN08242A1 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| TW200508208A (en) | Novel compound of 6-methyl-3-phenethyl-3,4-dihydro-1H-quinazoline-2-thione, its preparation and a depigmentation composition containing the same as an effective component | |
| DK1572715T3 (da) | Steroidforbindelser med antitumor-aktivitet | |
| UA96159C2 (ru) | КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ b-АГОНИСТОВ | |
| AU2003229202A1 (en) | Compositions comprising hepoxilin analogs and their use in the treatment of cancer | |
| AU8900498A (en) | Compounds and pharmaceutical compositions thereof for eliciting analgesic effects |